Zota Health Care Raises INR 350 Crore via QIP, Onboards MS Dhoni and Suniel Shetty as Brand Ambassadors

Surat (Gujarat) [India], December 25: Zota Health Care Limited (NSE: ZOTA), a leading generics pharmacy retailer in India, has raised Rs 350 crores from a group of marquee investors through a Qualified Institutional Placement (QIP) issue and signed former Indian cricket captain Mahendra Singh Dhoni and Bollywood actor Suniel Shetty as its brand ambassadors.

The Surat-headquartered company allotted 22,80,130 shares to eligible Qualified Institutional Buyers (QIBs), including foreign portfolio investors, alternative investment funds, and mutual funds, at an issue price of Rs. 1,535 per share. Investors who participated in the issue include Valiant Partners, 360 ONE, Prashant Jain-led 3P Investment Managers, White Oak Capital, Sanshi Fund-I and Turnaround Opportunities Fund, among others.

Commenting on the successful fundraiser, Ketan Zota, Chairman of Zota Health Care Limited, said the continued support from institutional investors reflected confidence in the company’s long-term strategy and business model.

 “We are grateful for the trust and support shown by our investors. It is particularly encouraging to see several existing investors participate in the QIP, reaffirming their belief in our vision and growth plans,” he said.

The proceeds from the QIP will be used primarily to accelerate the nationwide expansion of generic pharmacy stores. Zota Health Care aims to open more than 5,000 generic pharmacy stores across India by March 2029, supported by the fresh capital and cash flows from its mature store network.

“As of now, we operate 1,373 Company-Owned Company-Operated (COCO) stores and 880 Franchisee-Owned Franchisee-Operated (FOFO) stores across the country. In addition, around 400 COCO stores are at various stages of development,” Mr. Zota said.

Zota Health Care has witnessed steady improvement in per-store revenues, driven by increasing consumer awareness and growing demand for affordable medicines. The company focuses on offering quality generic medicines at significantly lower prices compared to branded alternatives, making essential medicines more accessible to a wider population.

Website – https://www.zotahealthcare.com/

Business HTL International

HTL International Drives Sustainable Living Through Thoughtful Design, Circular Innovation and Responsible Manufacturing

New Delhi [India], June 05: As sustainability continues to shape consumer choices and industry priorities, companies across sectors are re-evaluating how products are designed, sourced, and manufactured. At HTL International, environmental responsibility is increasingly embedded into every stage of the value chain, from material innovation and sourcing practices to manufacturing processes and product longevity. Across […]

Read More
Business

Mitsu Chem Plast Limited Scales Up – Announces ~2,550 MT/Year Capacity Addition at Khalapur

Mumbai (Maharashtra) [India], June 4: Mitsu Chem Plast Limited (BSE: 540078), a leading certified manufacturer of polymer-based molded products, is pleased to announce a significant capacity addition at its Unit 3 (Khalapur) facility in Maharashtra. The Company is adding approximately 2,550 MT/Year of manufacturing capacity, with the addition of new machinery financed through internal accruals. Key […]

Read More
Business Power 250

Maximus International Closes FY26 with 18% Revenue Growth and Record Q4 Performance

New Delhi [India], June 4: Maximus International Limited (BSE: 540401), a premier manufacturer and distributor of specialty lubricants and petroleum products, announced its Board-approved audited financial results for the quarter and financial year ended 31st March 2026 on 28th May 2026.  Maximus International Limited delivered a strong financial performance during the period, driven by higher business activity across its operating segments. The overall performance […]

Read More